Canberra, AustraliaFor, for, for,. March 24, 2025 / PR Newswear/ -Is, Volpara Health, a global leader and a subsidiary of Lot, announced two major milestones today in the AI-powered breast health solution:
-
The Valepra density is now a verified input of Bodesia breast cancer risk.
-
The ECR 2025 recorded a record of 21 independent summary features that featured the Lent and the Volpara solution.
Vulpra density now merged with Bodesia breast cancer model
The diagnosis of the Welpara ValueMometric breast density is now a verified input of the newly released version of the Bodesia breast cancer risk model. This indicates an important milestone, as the Wolfra density has now been integrated into two different risk -risk models of breast cancer.
Any wolf customer can use his vilpara density information through Cannes today. Centersk’s verification is made through international societies and guidelines for use AustraliaThe European Union, the United Kingdom, the United States, and Canada. Studies in Bodesia to improve the accuracy of the model, compared to the use of two reds density category, increasing the risk of breast cancer risk diagnosis for health care worldwide.
ECR 2025 recorded high 21 lumps and Welpra Research Summary
The European Congress of Radiolji (ECR) in 2025, the solution records of Lent and Wulpara were presented in the top 21 independent research summary. This milestone highlights the growing effects of breast health solutions in the global radiolism community, which reinforces the pursuit of woolra and lump cancer and pursuing patients’ care through innovation and scientific research.
About Volpra Health
Wulpara Health is on a mission to save families through AI -powered software that helps health care to better understand the risk of cancer, guide personal care decisions, and recommend additional imaging and intervention. More than 9,500 technicians worldwide are used in more than 3,500 facilities. The effect of Vulpra’s software takes close 18 meters Patients, more cooperating 3.6m Annual cancer risk diagnosis, and connects with no obstacles with electronic health records and imaging systems. Volparas help radiologists in the amount of dense tissue in which precision and technicians produce maximum positioning, compression and dose. The Welpra software also pushes operations to reduce compliance and approval. A Lent Company, Volpara’s headquarters is inside Wellington, New ZealandAnd it has an office Seattle. Volpra is a reliable partner of leading health care agencies globally. See for more information www.volparahealth.com.
